MD: the cash flow

MyFinsight

For the year ending 2025-12-31, MD had $145,301K increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net (loss) income attributable to pediatrix medical group, inc	165,388
Depreciation and amortization	21,827
Amortization of premiums, discounts and issuance costs	935
Impairment losses	0
Loss on disposal of businesses	0
Net gain on investments in divested businesses	20,906
Stock-based compensation expense	18,045
Deferred income taxes	52,186
Other	4,562
Accounts receivable	-30,558
Prepaid expenses and other current assets	2,920
Other long-term assets	-21,798
Accounts payable and accrued expenses	28,332
Income taxes (payable) receivable	-1,214
Long-term professional liabilities	-8,658
Other liabilities	-26,070
Net cash provided by operating activities - continuing operations	274,739
Net cash used in operating activities - discontinued operations	-3,648
Net cash provided by operating activities	271,091
Acquisition payments, net of cash acquired	23,196
Purchases of investments	29,851
Proceeds from maturities or sales of investments	26,674
Proceeds from investment in divested business	30,000
Purchases of property and equipment	18,458
Other	3,465
Net cash used in investing activities	-18,296
Net cash used in financing activities	-107,494
Net increase in cash and cash equivalents	145,301
Cash, cash equivalents at beginning of year	229,940
Cash and cash equivalents at end of year	375,241

Unit: Thousand (K) dollars (except for numbers of shares and EPS).